Mitchell P. Kopin 13D/13G Filings for

Mitchell P. Kopin 13D and 13G filings for :

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		Transaction
Date		TypeCompany
Symbol		Filed By
Symbol		Shares Owned
% Owned		Shares Vs. Prev ReportView
2025-01-15
4:03 pm
Purchase		2024-12-3113GPharmaCyte Biotech, Inc.
PMCB		Mitchell P. Kopin714,844
9.990%		714,844increase
(New Position)		Filing